Twist Bioscience (TWST) Gross Profit (2018 - 2025)

Twist Bioscience (TWST) has disclosed Gross Profit for 9 consecutive years, with $54.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 25.99% to $54.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $202.1 million through Dec 2025, up 37.3% year-over-year, with the annual reading at $191.0 million for FY2025, 43.23% up from the prior year.
  • Gross Profit for Q4 2025 was $54.0 million at Twist Bioscience, up from $50.8 million in the prior quarter.
  • The five-year high for Gross Profit was $54.0 million in Q4 2025, with the low at $12.2 million in Q1 2021.
  • Average Gross Profit over 5 years is $29.7 million, with a median of $25.4 million recorded in 2022.
  • The sharpest move saw Gross Profit surged 197.47% in 2021, then decreased 12.9% in 2023.
  • Over 5 years, Gross Profit stood at $15.0 million in 2021, then surged by 65.76% to $24.8 million in 2022, then increased by 16.78% to $29.0 million in 2023, then surged by 47.92% to $42.8 million in 2024, then grew by 25.99% to $54.0 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $54.0 million, $50.8 million, and $51.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.